A molecular method for the detection of Pseudomonas pseudomallei was developed on the basis of the differences in the 23S rRNA sequences of related species of the genus Pseudomonas. An 18-base oligonucleotide probe, designed following partial sequencing of 23S ribosomal DNA (rDNA), was used for the identification and detection of P. pseudomallei either by hybridization or by direct PCR. Optimal detection was obtained by hybridization of the probe with PCR-amplified rDNA rather than with total genomic DNA or colony blots. One nanogram of template DNA amplified in a PCR mixture containing 14% glycerol could be detected in slot blots hybridized with the digoxigenin-labelled probe and the lumigen PPD detection system. Amplified rDNA sequences from 41 P. pseudomallei strains of various origins hybridized with the probe. The probe also hybridized with three Pseudomonas mallei reference strains under conditions of high stringency but failed to hybridize with amplified rDNA sequences from other closely related Pseudomonas spp. PCR with a conserved primer and the 18-base oligonucleotide probe (direct PCR) specifically amplified P. pseudomallei and P. mallei.
Melioidosis, an infectious disease of humans and animals caused by Pseudomonas pseudomallei, is an important public health problem of increasing prevalence in southeastern Asia and northern Australia (1, 8) . The causative agent of melioidosis, P. pseudomallei, is a soil saprophyte which is thought to occupy an ecological niche similar to that of Pseudomonas cepacia (4), although its distribution has traditionally been considered to be more restricted, between 20°S and 20°N (11) . A problem in ascertaining the presence of P. pseudomallei in environmental specimens is isolating and differentiating the bacterium from the heterogeneous population of organisms that may be present (22) . Clinical investigations are similarly hampered because P. pseudomallei may be misidentified because of overgrowth by the normal flora that is commonly present in specimens (32) . Many epidemiological questions regarding melioidosis are still unanswered, in part because of the lack of a sensitive system for detecting this organism.
Yabuuchi et al. (39) have recently proposed that the species belonging to RNA homology group II of the genus Pseudomonas be transferred to a new genus, Burkholderia. Burkholderia pseudomallei and Burkholderia mallei were found to be genetically indistinguishable, but because of epidemiological dissimilarities, they have remained separate species (39) . P. mallei causes glanders, an exotic disease primarily of horses and mules that is not found in Australia, and reports of the disease in other countries are rare (1) . There have been no published reports in which, diagnostically, melioidosis and glanders have been confused.
Molecular method-based technology is continually being applied to the detection of many microorganisms in clinical specimens (17, 27, 31) and environmental sources (6) because of the potential utilities of rapid methods with improved sensitivities and specificities. The 16S and 23S ribosomal genes are suitable for use in the identification and detection of taxonomic groups because of the highly conserved nature of these genes (19) . In addition, the detection of rRNA can increase the sensitivity 1,000-fold or more because of the multiple copies of the target sequences present in a bacterium (20) . Oligonucleotide probes designed from rRNA sequences have enabled the specific detection of closely conserved bacterial species in environmental and clinical specimens (6, 26) . PCR has been used to increase the sensitivities of such probes by amplifying segments of ribosomal DNA (rDNA) before hybridization (24) . PCR of clinical samples has been enhanced by the development of simplified sample preparation procedures, which minimize the activities of inhibitory substances (7) .
The aim of the study described here was to sufficiently sequence the 23S rRNA of P. pseudomallei to construct an oligonucleotide probe that is able to specifically distinguish this species and to apply the developed techniques to the detection of the organism in artificially inoculated blood and sputum samples.
MATERUILS AND METHODS
Bacterial strains and DNA extraction. The P. pseudomallei strains and the Pseudomonas reference strains used in the study are summarized in Tables 1 and 2 , respectively. Strains were identified phenotypically according to the criteria described by Ashdown (2) . The tests included growth on the medium described by Ashdown (2), alkaline phosphatase production, gentamicin and colistin resistance, and glucose and maltose oxidation and fermentation. P. pseudomallei, P. cepacia, Pseudomonas aeruginosa, Pseudomonas stutzeri, Pseudomonas gladioli, Pseudomonas marginalis, and Pseudomonas pick- (Fig. 1) were initially selected from homologous 23S rRNA sequences of P. cepacia (16) and P. aeruginosa (35) to amplify a 1,550-bp fragment. All oligonucleotides described in Fig. 1 were synthesized on an Applied Biosystems 392 DNA synthesizer by using standard cyanoethyl phosphoramidite chemistry, desalted on Sephadex G-25, and lyophilized; the oligonucleotides were supplied by Bresatech Ltd., Australia. For PCR amplification, the template DNA was denatured in PCR buffer with glycerol at 94°C for 10 min by using a DNA thermal cycler (480; Perkin-Elmer, Norwalk, Conn.); this was followed by the addition of PCR reagents through the mineral oil overlay (hot start). The PCR reagent mixture consisted of Sequencing. The 23S rDNA PCR products from P. pseudomallei were prepared with the conserved primers PPMA and PPMC under the conditions described above. Unincorporated PCR primers and deoxynucleotide triphosphates were removed by using a Prep-a-Gene DNA binding matrix (Bio-Rad Laboratories, Richmond, Calif.). The fragments were sequenced by the dideoxy-chain termination method (30) by using the Sequenase version 2.0 sequencing kit (U.S. Biochemical Corp., Cleveland, Ohio) and by following the conditions for the direct sequencing of PCR products described by Dorsch and Stackebrandt (13) . Primers PPMB2 and PPMC were used for sequencing.
Nucleotide sequence accession number. The partial sequence data for P. pseudomallei 23S rDNA have been deposited in GenBank under accession number U02305.
Probe design, application to hybridization, and direct PCR. The 388-bp sequences from P. pseudomallei NCTC 4845 and NCTC 6700 were compared with P. cepacia 23S rRNA sequences (16) by using the DNASIS software program (Pharmacia Biochemicals Inc., Milwaukee, Wis.). An 18-base oligonucleotide probe, PPM2 ( Fig. 1) , was selected from an area with the greatest sequence variation and was synthesized by Bresatech Ltd. as described above. For hybridization, the probe was end labelled with digoxigenin by using the Genius 6 oligonucleotide tailing kit as described by the manufacturer (Boehringer Mannheim GmbH). Primer PPM2 in combination with primer PPMB2 or PPMA (direct PCR) was used to amplify P. pseudomallei directly, producing products of approximately 75 or 1,125 bp, respectively. PCR was performed at an annealing temperature of 50°C, and the remaining PCR parameters were as described above. The products resulting from PCR with PPM2 and PPMB2 were electrophoresed in Visigel (Stratagene, La Jolla, California), which was prepared in accordance with the manufacturer's instructions.
VOL. 32, 1994 on Slot and colony blot preparation and Southern transfer. Slot blots were prepared with genomic DNA and with PCR products amplified by using primers PPMA and PPMC. Ten micrograms of genomic DNA and 1/10th of the 100-,ul PCR product amplified from the 41 P. pseudomallei isolates (Table  1) and Pseudomonas spp. (Table 2) were vacuum blotted onto a nylon membrane by using a slot blot manifold (Bio-Rad Laboratories). Samples were diluted in 200 [lI of 6 x SSC (1 x SSC is 0.15 M NaCl plus 0.015 M sodium citrate), heat denatured, and placed on ice prior to blotting. Slot blot transfer onto a positively charged nylon membrane (Boehringer Mannheim GmbH) was achieved by following the manufacturer's (Bio-Rad Laboratories) instructions. Colony blots on nylon membranes were prepared by using the Pseudomonas spp. (Table 2 ) and the five P. pseudomallei National Collection of Type Cultures (NCTC) strains by the method of Ausubel et al. (5) . DNA transfer of PCR products from 1% agarose gels was achieved by using the VacuGene XL vacuum blotting system (Pharmacia LKB Biotechnology AB, Uppsala, Sweden) in accordance with the manufacturer's instructions.
Hybridization and detection. Prehybridization and hybridization with the digoxigenin-labelled probe and detection with lumigen PPD was performed according to the Genius System User's Guide supplied by the manufacturer (Boehringer Mannheim GmbH). Membranes were prehybridized for 2 h and were hybridized with 10 pmol of the digoxigenin-labelled oligonucleotide PPM2 per ml overnight at 45°C in a hybridization incubator (Robbins Scientific, Calif.). Prior to blocking, the membranes were washed at room temperature twice in 2 x SSC-0. 1% sodium dodecyl sulfate (SDS) for 5 min and twice in 0.5 x SSC-0.1% SDS for 15 min (12) and heated at 95°C for 15 min. The suspension was placed on ice for 5 min and was centrifuged at 12,000 x g for 30 s, and 10 RI of the supernatant was used in subsequent PCRs. PCR with a variety of combinations of primers showed that PPMB2-PPMC (indirect PCR) produced a 500-bp product and PPMB2-PPM2 (direct PCR) could amplify products from crude extracts. These combinations were applied to subsequent reactions for amplification of products from crude samples and biological extracts.
Inoculation and preparation of clinical samples for PCR. P. pseudomallei NCTC 4845 was grown overnight in the broth described by Ashdown (2) (Fig. 3A) . The application of a minimum of 1 pul of amplified product from 1 p.g of template DNA to the slot blot was detectable (Fig. 3B) . By the latter method, the application of >20 p.l of product produced a signal confined to the periphery of the slot, while the lower volumes (optimally, 2 [l for this particular PCR product) resulted in a clearer signal covering the total defined area. Therefore, the application of too much PCR product to a slot blot could result in confusion of the actual hybridization outcome (10 p.l was accepted as the general optimal volume that should be used). B, lanes al to aS) or by PCR with PPMB2-PPM2 (data not shown). A very faint hybridization reaction was observed at 6.7
x 103 cells per ml (Fig. 4B, lane a3) . A total of 2.3 x 102 cells per ml blood were detected following enrichment for 24 h (Fig.   4A and B, lanes a6 to alO), when the blood culture concentration was 9.6 x 107 cells per ml ( (2) containing no antibiotics.
prior to the Chelex treatment and PCR preparation (Fig. 4A  and B, lanes all to al5) . PCR products were detected in 20 ,ul of blood containing 3.2 x i04 cells per ml dried on filter paper (Fig. 4A and B, lanes b7 to bll) . No PCR products were 5 . PCR products prepared from sputum sample 1 by using P. pseudomallei and P. mallei-specific primer PPM2 and conserved primer PPMB2 electrophoresed in Visigel-TAE buffer. The molecular size marker (base pairs) was DNA marker V (Boehringer Mannheim); positive (+) and negative (-) controls contained purified P. pseudomallei DNA and no DNA, respectively. Lanes 1 to 5, uninoculated sputum and sputum with dilutions 1 to 4 ( FIG. 4. Detection of P. pseudomallei artificially inoculated into blood and sputum by PCR amplification with conserved primers PPMB2-PPMC and hybridization with a digoxigenin-labelled PPM2 probe detected with lumigen PPD. (A) Ethidium bromide-stained PCR products electrophoresed in 1% agarose-TAE gels; (B) Southern blot hybridizations. DNA marker VI (Boehringer Mannheim) was used as the molecular size marker (base pairs); positive (+) and negative ( -) controls contained purified P. pseudomallei DNA and no DNA, respectively. PCR samples included uninoculated blood (lanes al, a6, all, and b7) and blood inoculated with dilutions 1 to 4 (Table  3 ) and were treated as follows: direct, lanes al to aS; enrichment, lanes a6 to alO; concentrated 0.5-ml volumes, lanes all to alS; and filter paper disks, lanes b7 to bll. PCR of sputa included uninoculated sputum sample 1 (lane bl), and sputum with dilutions 1 to 4 (Table 3) (lanes b2 to b5); dilution of sputum sample 2 to 1.5 x 103 CFU/ml (lane b6). detected in the negative controls. The detection time, starting from the time of preparation of the sample for PCR until the time that hybridization results were available, was approximately 24 h. The time that it took to obtain a result from direct PCRs was approximately 5 h. The inclusion of the concentration step added approximately 15 min to the overall sample preparation procedure. Approximately 1.5 x 103 cells of P. pseudomallei per ml were detected in both sputum samples ( Fig. 4A and B, lanes bl to b6) by using primers PPMB2-PPMC and hybridization with probe PPM2. Products were amplified from both uninoculated and inoculated sputum samples; however, the probe did not hybridize with uninoculated sputum samples. Direct PCR with primers PPM2-PPMB2 produced weak bands from the inoculated samples but not from the uninoculated samples (Fig. 5) . A Klebsiella sp. and P. aeruginosa were isolated from uninoculated sputum samples 1 and 2, respectively.
DISCUSSION
The current methods used to detect P. pseudomallei from clinical or environmental samples involve isolation and phenotypic characterization of the bacterium (3, 4) . The bacterium can be isolated by using routine culture media, although this has been more easily achieved for isolation of organisms from clinical specimens obtained from usually sterile body sites. Isolation of P. pseudomallei from clinical specimens from nonsterile body sites (e.g., sputum) and environmental samples is less successful because P. pseudomallei may be overgrown by competing normal flora (10) . The development of enrichment or solid media such as Ashdown medium (2) has offered a more selective isolation process; however, P. pseudomallei remains subject to misidentification because of its variable colony morphology and its close phenotypic relationship with other Pseudomonas spp. In Thailand, where melioidosis is endemic, the misidentification of P. pseudomallei from clinical specimens as P. cepacia or P. stutzeri is not uncommon because of the similar biochemical characteristics, colony morphologies, and antibiotic susceptibility patterns of the organisms (21, 32) . P. pseudomallei and P. cepacia are the most frequently confused organisms, because they can both be resistant to gentamicin and colistin (9) .
PCR and hybridization have the potential to provide an alternative procedure for detecting and identifying P. pseudomallei. rRNA sequences are highly specific for most organisms and are the basis for the definition of phylogenetic relationships and species identification (34) . Theoretically, one could design oligonucleotide probes which are capable of discriminating rRNAs that differ by a single nucleotide (36) and PCR can be used to amplify the target sequences. In the present study, we investigated the feasibility of using these techniques to detect P. pseudomallei.
We succeeded in developing a probe which specifically detected P. pseudomallei and P. mallei. Hybridization with P. mallei rDNA was not surprising because of the similarities between these species. Antigenically, the two species are similar (25) ; and cellular lipids, fatty acid composition, DNA-DNA homology values, and 16S rRNA sequences have been used to demonstrate their close genetic similarities (39) . Melioidosis bears a striking resemblance to glanders, both clinically and in pathology, but it is epidemiologically dissimilar (29) . Melioidosis is endemic in southeastern Asia and the tropics (11) , whereas glanders was widespread throughout Europe (29) . Unlike melioidosis, which is pathogenic for a wide range of animals, glanders is primarily a disease of horses, mules, and donkeys, and other animals are rarely or are not susceptible. Glanders is now rare because of control measures and the replacement of horse-drawn vehicles with mechanical conveyances (1) , although sporadic cases of glanders still occur in animals in Asia, Africa, and South America (29) . While the detection of both P. pseudomallei and P. mallei is a limitation of this procedure, it is not considered a problem in countries where melioidosis is endemic but glanders is exotic, e.g., Australia. When both diseases are present, the differences in the phenotypic characteristics of the species could be used in selective isolation techniques prior to PCR.
The difficulty in obtaining amplified products for sequence analysis in the present study led to the investigation of various PCR conditions for the optimization of P. pseudomallei DNA amplification. Glycerol has been found to be a useful cosolvent to enhance PCR amplification of GC-rich DNA templates and for the amplification of long fragments (33) . The addition of the solvent to the PCR mixture resolved the amplification difficulties that were likely due to the high GC content ratio of the DNA of P. pseudomallei. Variation in the intensity of the slot blot hybridization signals obtained with PCR products from the P. pseudomallei strains could be explained by strain-to-strain variation in the number of target DNA copies, either by the presence of extraneous rRNA or by the presence of various numbers of rDNA gene copies. Multiple copies of genes coding for Escherichia coli rRNA have been described previously (37) . The probe and PCR described here can be used for both the detection and the identification of P. pseudomallei. The clinical isolates included in the study had colony morphologies and phenotypic profiles typical of P. pseudomallei, in contrast to the soil isolates, which had variable colony morphologies but otherwise conformed with commonly used identification criteria (2) . Strain 479 was originally identified by the donor public health laboratory as P. pseudomallei, but it did not hybridize with the probe. This strain had the phenotypic traits (2) of P. pseudomallei but had a colony morphology on Ashdown medium (2) identical to that of the reference P. cepacia strain. (12) . Chelex-100 and heat treatment have been used to prepare extracts suitable for gene amplification from pure cultures (12) and clinical samples (18) . We found that this was not successful for P. pseudomallei by using primers that amplify fragments larger than 1,000 bp, but was effective with primers that amplify products of 500 bp or less.
There is no information available on the concentration of P. pseudomallei present in clinical specimens. Freeman (14) reported that the concentration of bacterial cells in blood samples from septicemic patients is often less than 1/ml. Some cases of septicemic melioidosis are confirmed only after 7 days of blood culture (38) , and Thai researchers recommend that blood cultures be observed for up to 2 weeks (32), suggesting that the number of bacteria present may be low. The detection levels determined in the present study were much less sensitive, and alternate preparatory methods for concentrating target nucleic acid, including the direct detection of rRNA (17, 24) , are being evaluated. The methods evaluated could be made more sensitive by concentrating the cells from larger blood volumes prior to Chelex treatment.
Regardless of the requirement for hybridization, PCR offers a more rapid diagnostic test. Patients with septicemic melioidosis, particularly those with fulminant melioidosis, may die before blood cultures become positive (8) . P. pseudomallei is resistant to many empirical antibiotics; thus, the timing for treatment with the correct regimen is critical for patient management (1) . Detection of the organism may be possible within 5 to 24 h, depending on the number of cells present. These techniques require clinical evaluation in parallel with culture and serological diagnostic tests.
The lung is the most common site of involvement in localized melioidosis (9) . In a Thai study of septicemic melioidosis (8) , it was observed that the primary source of infection of almost a quarter of the cases was pneumonia. Lung involvement can be primary or secondary to septicemia (9) . In the case of a primary infection of pulmonary melioidosis, a highly purulent sputum is produced (9) . Approximately 103 cells per ml of sputum were detected either by direct PCR or following PCR and hybridization. The concentration of P. pseudomallei expected in sputum would vary considerably, depending on the severity of the disease and the quality of the specimen. The sputum specimens used in the present study were contaminated with other species, in particular, a Pseudomonas sp., which would account for the PCR products that were amplified; however, hybridization confirmed the presence of PCR products homologous to P. pseudomallei.
The application of PCR and hybridization in diagnostic laboratories may not be feasible in some areas where melioidosis is endemic at present; however, advances in the techniques and the development of user-friendly adaptations of the techniques are progressing rapidly. The potential to detect the bacterium in blood dried on filter paper offers a mechanism for the transport of specimens from areas with limited laboratory facilities to a central laboratory. Evaluation of this technique for use with environmental isolates of P. pseudomallei is in progress. The detection of P. pseudomallei in other clinical samples, e.g., pus, which is commonly encountered with melioidosis, also requires attention. The technique offers considerable potential for use in the diagnosis and the detection of P. pseudomallei and as a tool for further research into the pathogenesis of melioidosis.
